← Evidence map

ArticleBMC neurology2015

Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.

Ola Caster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26475456